Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ri-Schedule: Rivaroxaban for Suspected DVT
NCT02486445Phase 3Completed
- Sponsor
- Ostfold Hospital Trust
- Start
- Mar 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in deep vein thrombosis (DVT), sponsored by Ostfold Hospital Trust. Started Mar 2015; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT02486445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02486445.